Search Results - Gurwith, Marc

Refine Results
  1. 1
    Gastroenteritis in Children: A Two-Year Review in Manitoba. I. Etiology

    Gastroenteritis in Children: A Two-Year Review in Manitoba. I. Etiology by Gurwith, Marc J., Williams, Trevor W.

    Published 1977
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Prospective Comparison of Cefoxitin and Cefazolin in Infections Caused by Aerobic Bacteria

    Prospective Comparison of Cefoxitin and Cefazolin in Infections Caused by Aerobic Bacteria by Gurwith, Marc, Albritton, William, Lank, Beverley, Harding, Godfrey, Ronald, Allan

    Published 1978
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    A Prospective Study of Rotavirus Infection in Infants and Young Children

    A Prospective Study of Rotavirus Infection in Infants and Young Children by Gurwith, Marc, Wenman, Wanda, Hinde, Dorothy, Feltham, Sheila, Greenberg, Harry

    Published 1981
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    LC16m8: An attenuated smallpox vaccine

    LC16m8: An attenuated smallpox vaccine by Kenner, Julie, Cameron, Fiona, Empig, Cyril, Jobes, David V., Gurwith, Marc

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population

    Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population by Haney, Douglas J., Lock, Michael D., Simon, Jakub K., Harris, Jason, Gurwith, Marc

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    AIDSVAX Immunization Induces HIV-specific CD8+ T-cell Responses in High-risk, HIV-negative Volunteers Who Subsequently Acquire HIV Infection

    AIDSVAX Immunization Induces HIV-specific CD8+ T-cell Responses in High-risk, HIV-negative Volunteers Who Subsequently Acquire HIV Infection by Jones, Norman G, DeCamp, Allan, Gilbert, Peter, Peterson, Michael L, Gurwith, Marc, Cao, Huyen

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Age, Race/Ethnicity, and Behavioral Risk Factors Associated with Per-Contact Risk of HIV Infection Among Men Who Have Sex with Men in the United States

    Age, Race/Ethnicity, and Behavioral Risk Factors Associated with Per-Contact Risk of HIV Infection Among Men Who Have Sex with Men in the United States by Scott, Hyman M., Vittinghoff, Eric, Irvin, Risha, Sachdev, Darpun, Liu, Albert, Gurwith, Marc, Buchbinder, Susan P

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Safety and Immunogenicity of Single-Dose Live Oral Cholera Vaccine Strain CVD 103-HgR, Prepared from New Master and Working Cell Banks

    Safety and Immunogenicity of Single-Dose Live Oral Cholera Vaccine Strain CVD 103-HgR, Prepared from New Master and Working Cell Banks by Chen, Wilbur H., Greenberg, Richard N., Pasetti, Marcela F., Livio, Sofie, Lock, Michael, Gurwith, Marc, Levine, Myron M.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    High and Persistent HIV Seroincidence in Men Who Have Sex with Men across 47 U.S. Cities

    High and Persistent HIV Seroincidence in Men Who Have Sex with Men across 47 U.S. Cities by Ackers, Marta-Louise, Greenberg, Alan E., Lin, Carol Y., Bartholow, Bradford N., Goodman, Adrian Hirsch, Longhi, Michael, Gurwith, Marc

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety

    The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety by Black, Steven B., Law, Barbara, Chen, Robert T., Dekker, Cornelia L., Sturkenboom, Miriam, Huang, Wan-Ting, Gurwith, Marc, Poland, Greg

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus

    A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus by Hernandez, Libia Milena, Sumathy, K., Sahastrabuddhe, Sushant, Excler, Jean-Louis, Kochhar, Sonali, Smith, Emily R., Gurwith, Marc, Chen, Robert T.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization

    Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization by Khurana, Surender, Coyle, Elizabeth M., Manischewitz, Jody, King, Lisa R., Ishioka, Glenn, Alexander, Jeff, Smith, Jon, Gurwith, Marc, Golding, Hana

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Treatment of Invasive Fungal Infections in Renally Impaired Patients with Amphotericin B Colloidal Dispersion

    Treatment of Invasive Fungal Infections in Renally Impaired Patients with Amphotericin B Colloidal Dispersion by Anaissie, Elias J., Mattiuzzi, Gloria N., Miller, Carole B., Noskin, Gary A., Gurwith, Marc J., Mamelok, Richard D., Pietrelli, Larry A.

    Published 1998
    Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)

    A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273) by Leav, Brett, Straus, Walter, White, Phil, Leav, Alison, Gaines, Tashawnee, Maggiacomo, Grace, Kim, Denny, Smith, Emily R., Gurwith, Marc, Chen, Robert T.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Live Adenovirus Type 4 Recombinants Induce Durable Neutralizing Antibody Responses to Influenza H5 with High Levels of Somatic Hypermutation in Humans

    Live Adenovirus Type 4 Recombinants Induce Durable Neutralizing Antibody Responses to Influenza H5 with High Levels of Somatic Hypermutation in Humans by Huang, Jinghe, Kang, Byong, Wheatley, Adam, Narpala, Sandeep, Mcdermott, Adrian, Poole, April, Bailer, Robert, Koup, Richard, Migueles, Stephen, Gurwith, Marc, Connors, Mark

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment

    Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment by Folegatti, Pedro M, Jenkin, Daniel, Morris, Susan, Gilbert, Sarah, Kim, Denny, Robertson, James S., Smith, Emily R., Martin, Emalee, Gurwith, Marc, Chen, Robert T.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

    Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study by Gurwith, Marc, Lock, Michael, Taylor, Eve M, Ishioka, Glenn, Alexander, Jeff, Mayall, Tim, Ervin, John E, Greenberg, Richard N, Strout, Cynthia, Treanor, John J, Webby, Richard, Wright, Peter F

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines

    Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines by Kochhar, Sonali, Excler, Jean-Louis, Bok, Karin, Gurwith, Marc, McNeil, Michael M., Seligman, Stephen J., Khuri-Bulos, Najwa, Klug, Bettina, Laderoute, Marian, Robertson, James S., Singh, Vidisha, Chen, Robert T.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines

    The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines by Condit, Richard C, Kim, Denny, Robertson, James S., Excler, Jean-Louis, Gurwith, Marc, Monath, Thomas P., Pavlakis, George, Fast, Patricia E., Smith, Jonathan, Smith, Emily R., Chen, Robert T., Kochhar, Sonali

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge

    Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge by Espinosa, Diego, Mendy, Jason, Manayani, Darly, Vang, Lo, Wang, Chunling, Richard, Tiffany, Guenther, Ben, Aruri, Jayavani, Avanzini, Jenny, Garduno, Fermin, Farness, Peggy, Gurwith, Marc, Smith, Jon, Harris, Eva, Alexander, Jeff

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: